Key statistics
As of last trade, Quince Therapeutics Inc (QNCX:NSQ) traded at 0.732, 43.08% above the 52 week low of 0.5116 set on Aug 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.745 |
---|---|
High | 0.76 |
Low | 0.732 |
Bid | 0.732 |
Offer | 0.75 |
Previous close | 0.76 |
Average volume | 92.74k |
---|---|
Shares outstanding | 43.28m |
Free float | 37.33m |
P/E (TTM) | -- |
Market cap | 32.89m USD |
EPS (TTM) | -1.27 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:00 BST.
More ▼
- Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)
- Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
- Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia